Private Equity 24 Hours

Last updated: April 4, 2026, 11:30 AM ET

Fundraising & Secondaries Activity

KKR securing $23bn for its North America Fund XIV signals continued strong appetite for large-scale buyouts, even as managers increasingly look toward secondary markets to manage portfolio shifts. Lead Edge's seventh flagship fund is specifically tapping secondaries strategies, reflecting broader industry adjustments driven by the rapid pace of AI-related investments that are reshaping valuations across technology sectors. This activity comes as investors closed out a busy week of dealmaking, with major financings across defense, wearables, and energy infrastructure topping the charts, notably a $1.75 billion Series D for autonomous vessel developer Saronic.

Technology & Healthcare Acquisitions

The technology and healthcare services sectors saw several strategic carve-outs and platform expansions executed by private equity sponsors. Anthropic pursuing Coefficient Bio underscores the high-stakes M&A environment in AI, where the generative AI leader purchased the stealth biotech startup for a reported $400 million in stock. Concurrently, platform companies are scaling through bolt-on acquisitions; Advent Partners-backed efex acquired Priority 1 IT to bolster its technical capabilities, especially within the healthcare domain, while Court Square purchased cloud communications firm Call Tower from BV Investment to deepen its Unified Communications as a Service (UCaa S) footprint.

Infrastructure & Life Sciences Exits

Sponsors are realizing value in specialized infrastructure and pharmaceutical assets. GHO Capital divesting VISUfarma to Lupin Limited is set to immediately boost the Indian pharmaceutical firm's European specialty franchise presence. In the energy transition space, FlexGen expanding its reach by acquiring Clean Energy Services will create an integrated model aimed at accelerating project delivery for utility-scale energy storage customers, strengthening asset reliability across its portfolio.